Testing The Most Curious Subject -- Oneself

One July day in 1984, Barry Marshall, a medical resident at the Fremantle Hospital in Perth, Western Australia, walked over to his lab bench, pulled down a beaker, and mixed a cocktail. The key ingredient: about a billion Helicobacter pylori bacteria. Marshall hoped to show that the microorganism causes ulcers. He gulped the concoction, describing it as "swamp water." PHYSICIAN, STUDY THYSELF: Barry Marshall's daring experiment eventually garnered him awards. One hundred years earlier, Max vo

Written byKathryn Brown
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Barry Marshall PHYSICIAN, STUDY THYSELF: Barry Marshall's daring experiment eventually garnered him awards.

Marshall was correct. He suffered an inflamed stomach. Von Pettenkofer was incorrect. He was fortunate to survive. Both researchers risked their health-and, perhaps, their lives-to prove a scientific point. And they are not alone.

Since the earliest days of medicine, self-experimenting researchers have swallowed microbes, injected vaccines, followed deprivation diets, and even performed their own surgeries. Aside from health hazards, these unorthodox experimenters risk the incredulity of peers accustomed to formal subject studies. If a self-experiment is unsuccessful, an investigator's reputation -- and funding -- may be in jeopardy.

So why self-experiment? Belief in a hypothesis. Curiosity. Convenience. Ethics. Desperation. A medley of motivations stands behind self-experimentation. Usually, researchers double as subjects because it appears both practical and ethical.

"I was so frustrated," recalls Marshall, now a gastroenterologist at the University of Virginia. "I had been trying to infect ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies